Benjamin Rowlatt advises clients in relation to intellectual property (IP) disputes, with a particular focus on patents. He leverages his experience and scientific technical background to represent clients in complex life sciences matters and high-tech fields. In addition to representing clients in the UK courts, Ben’s matters frequently call for coordinating cross-border litigation, necessitating collaboration with counsel teams throughout Europe, at the European Patent Office, and Unified Patent Court.
Ben’s practice focuses on complex IP disputes, through which matters he has cultivated an extensive background with both UK and wider multijurisdictional European litigation.
With his first degree in chemistry, Ben handles all manner of chemical, pharmaceutical, and biotech patent litigation, with a diverse practice spanning small molecule drugs, antibody therapies, drug manufacturing, therapeutic applications, DNA sequencing, biopesticides, and more. Ben’s life sciences matters also often see him working at the interface of IP law and pharmaceutical regulatory issues, such as research exemptions and Supplementary Protection Certificates.
Ben also advises on patent cases dealing with all manner of technologies, including telecommunications, computer networking, as well as mechanical and electrical engineering.
In addition to litigation before the UK courts, a significant proportion of Ben’s practice involves multijurisdictional disputes. Ben’s matters have seen him at the forefront of coordinating local counsel teams in parallel litigation across Europe, as well as attending hearings in an array of European national courts and at the European Patent Office. The establishment of the Unified Patent Court in Europe has also seen Ben expand his coordination experience to include this extra dimension.
Recommended, IP-Patents, Lexology (2024)
Member, International Association for the Protection of Intellectual Property (AIPPI)